Manufacturing Locations
You Can Trust
All manufacturing is performed in Switzerland & South Korea.
By maintaining production outside of China, we retain greater oversight of manufacturing operations, stronger process control, and enhanced supply chain integrity, ensuring the consistency, quality, and reliability expected of premium peptide products.
Why Switzerland
& South Korea
Both manufacturing nations are recognized for precision industrial manufacturing, structured regulatory frameworks, and pharmaceutical-grade process discipline. Our non-China manufacturing position is a deliberate strategic choice — not a default.
This enables higher regulatory alignment with FDA, EMA, and international health authorities, while delivering more consistent supply chain predictability for our partners.
Peptide Formats
Vials
- Liquid Vials
- Lyophilized (Powder) Vials
Cartridges
- Liquid Formulations
Pen & Cartridges
- Pen only
- Pen with one cartridge
- Pens with bespoke cartridge options
Supplements
- Capsules / Tablets
- Sublinguals
- Dermal Patches
Manufacturing & Packaging
- GMP-Compliant Filling
- Sterile Manufacturing
- Custom Labelling & Packaging
SUPPLY CHAIN & COST EFFICIENCY
Integrated Supply. Predictable Costs.
Reduced Supply Variability
By aligning synthesis operations near key raw material sources, we eliminate variability from multi-tier, multi-country supply chains.
Shortened Production Cycles
Proximity to qualified API suppliers and integrated in-house testing reduces lead times across every production phase.
Improved COGS Efficiency
Strategic sourcing from 30+ countries gives access to competitive raw material pricing without sacrificing quality or traceability.
Long-Term Supply Integrity
Our infrastructure supports long-term global supply contracts with stability, predictability, and regulatory documentation continuity.
0+
Global Clients
Ready to Scale?
START YOUR PROJECT

